{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T14:09:01Z","timestamp":1787062141670,"version":"build-2736575974"},"reference-count":56,"publisher":"BMJ","issue":"6","content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["J Clin Pathol"],"accepted":{"date-parts":[[2024,12,30]]},"published-print":{"date-parts":[[2025,6]]},"abstract":"<jats:sec>\n                    <jats:title>Aims<\/jats:title>\n                    <jats:p>The prognostic impact of B lymphocytes surrounding Hodgkin and Reed Sternberg (HRS) cells in classic Hodgkin lymphoma (cHL) and pathogenic variants in genes associated with apoptosis regulation remains undefined.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We have quantified the proportion of B lymphocytes in tumour microenvironment (TME) in 220 diagnostic slides from 110 cHL patients applying computational pathology (CP) and sequenced cases using a targeted panel including 47 genes recurrently mutated in mature B-cell neoplasms. Kaplan\u2013Meier estimators and multivariate Cox regression on overall survival (OS) and progression-free survival (PFS) were assessed following the Transparent Reporting of a multivariable prediction model for Individual Prognosis Or Diagnosis guidelines.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>The mean percentage of B lymphocytes was 45.1 (SD: 24.8). Genes recurrently affected by nonsynonymous somatic mutations in 25% or more of patients included EP300, NOTCH and ABL1. A lower number of mutations were discovered in Epstein\u2013Barr virus-positive cHL (21.1% vs 78.8%) reinforcing the notion that viral infection could functionally replace the need for genomic aberrations. Classic Hodgkin lymphoma (cHL) patients that jointly presented a reduction in the number of B lymphocytes in TME (&lt;8%) and the absence of mutations in apoptosis-associated genes (ABL1, BIRC3, CASP8 and FAS) presented a lower OS (mean OS: 31.5 months, 95%\u2009CI: 0 to 69.7 months) in comparison with patients without this event (mean OS: 84.7 months, 95%\u2009CI: 61.9 to 107.5 months) (p=0.01). This high-risk cHL subgroup also presented a significantly lower PFS (mean PFS: 8.5 months, 95%\u2009CI: 7.5 to 9.5 months) in comparison with B-cell-enriched or apoptosis-mutated cHL (mean PFS: 55.2 months; 95%\u2009CI: 42.4 to 68 months) (p&lt;0.001).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>This study expands previous data on the value of CP in cHL, and specifically, the distribution of B cells, identifying patients with an increased risk of treatment failure and progression. Furthermore, immune escape by apoptosis dysregulation during clonal selection occurring in germinal centres constitutes a landmark of cHL. These results could be the basis for further development of targeted therapies directed against apoptosis modulators in cHL.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1136\/jcp-2024-209848","type":"journal-article","created":{"date-parts":[[2025,1,21]],"date-time":"2025-01-21T02:35:14Z","timestamp":1737426914000},"page":"381-389","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":1,"title":["Computational pathology identifies a low B-cell content in the tumour microenvironment as a predictor of adverse outcome in patients with classic Hodgkin lymphoma treated with ABVD"],"prefix":"10.1136","volume":"78","clinical-trial-number":[{"clinical-trial-number":"nct05355051","registry":"10.18810\/clinical-trials-gov"},{"clinical-trial-number":"nct02961101","registry":"10.18810\/clinical-trials-gov"},{"clinical-trial-number":"nct03250962","registry":"10.18810\/clinical-trials-gov"}],"author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0827-4263","authenticated-orcid":false,"given":"Antonio","family":"Santisteban-Espejo","sequence":"first","affiliation":[{"name":"Department of Medicine and Surgery, Faculty of Medicine, University of Cadiz, Cadiz, Andaluc\u00eda, Spain"},{"name":"Institute of Research and Biomedical Innovation of Cadiz, Cadiz, Andalucia, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristian","family":"Benavides-De la Fuente","sequence":"additional","affiliation":[{"name":"Department of Pathology, Puerta del Mar University Hospital, Cadiz, Andaluc\u00eda, Spain"},{"name":"Health Sciences Program, Doctoral School, University of Cadiz, Cadiz, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alipio","family":"Mangas-Rojas","sequence":"additional","affiliation":[{"name":"Department of Medicine and Surgery, Faculty of Medicine, University of Cadiz, Cadiz, Andaluc\u00eda, Spain"},{"name":"Institute of Research and Biomedical Innovation of Cadiz, Cadiz, Andalucia, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pedro","family":"Montero-Pavon","sequence":"additional","affiliation":[{"name":"Department of Pathology, Hospital San Agustin, Linares Jaen, Andaluc\u00eda, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irene","family":"Bernal-Florindo","sequence":"additional","affiliation":[{"name":"Institute of Research and Biomedical Innovation of Cadiz, Cadiz, Andalucia, Spain"},{"name":"Department of Pathology, Jerez de la Frontera University Hospital, Jerez de la Frontera, Andaluc\u00eda, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eduardo","family":"Aldaco-Puntas","sequence":"additional","affiliation":[{"name":"Department of Medicine and Surgery, Faculty of Medicine, University of Cadiz, Cadiz, Andaluc\u00eda, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabel","family":"Prieto-Conde","sequence":"additional","affiliation":[{"name":"Department of Medicine and Surgery, Faculty of Medicine, University of Cadiz, Cadiz, Andaluc\u00eda, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jose","family":"Perez-Requena","sequence":"additional","affiliation":[{"name":"Department of Pathology, Puerta del Mar University Hospital, Cadiz, Andaluc\u00eda, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lidia","family":"Atienza-Cuevas","sequence":"additional","affiliation":[{"name":"Department of Pathology, Puerta del Mar University Hospital, Cadiz, Andaluc\u00eda, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria del Carmen","family":"Fern\u00e1ndez-Valle","sequence":"additional","affiliation":[{"name":"Department of Hematology and Hemotherapy, Puerta del Mar University Hospital, Cadiz, Andaluc\u00eda, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sebastian","family":"Garz\u00f3n-L\u00f3pez","sequence":"additional","affiliation":[{"name":"Department of Hematology, Jerez de la Frontera University Hospital, Jerez de la Frontera, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcial","family":"Garcia-Rojo","sequence":"additional","affiliation":[{"name":"Institute of Research and Biomedical Innovation of Cadiz, Cadiz, Andalucia, Spain"},{"name":"Department of Pathology, Jerez de la Frontera University Hospital, Jerez de la Frontera, Andaluc\u00eda, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2025,1,20]]},"reference":[{"key":"2025120619125878000_78.6.381.1","doi-asserted-by":"publisher","DOI":"10.1038\/s41375-021-01204-6"},{"key":"2025120619125878000_78.6.381.2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.91.23.10962"},{"key":"2025120619125878000_78.6.381.3","doi-asserted-by":"publisher","DOI":"10.1084\/jem.184.4.1495"},{"key":"2025120619125878000_78.6.381.4","doi-asserted-by":"publisher","DOI":"10.1111\/bjh.18083"},{"key":"2025120619125878000_78.6.381.5","doi-asserted-by":"crossref","DOI":"10.1038\/s41408-019-0195-7","article-title":"Genomic analyses of microdissected Hodgkin and Reed-Sternberg cells: mutations in epigenetic regulators and p53 are frequent in refractory classic Hodgkin lymphoma","volume":"9","author":"Mata","year":"2019","journal-title":"Blood Cancer J"},{"key":"2025120619125878000_78.6.381.6","doi-asserted-by":"crossref","DOI":"10.3390\/ijms25052457","article-title":"Pathogenic Variants Associated with Epigenetic Control and the NOTCH Pathway Are Frequent in Classic Hodgkin Lymphoma","volume":"25","author":"Santisteban-Espejo","year":"2024","journal-title":"Int J Mol Sci"},{"key":"2025120619125878000_78.6.381.7","doi-asserted-by":"publisher","DOI":"10.1182\/bloodadvances.2023010412"},{"key":"2025120619125878000_78.6.381.8","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-023-06903-x"},{"key":"2025120619125878000_78.6.381.9","doi-asserted-by":"publisher","DOI":"10.1111\/bjh.19162"},{"key":"2025120619125878000_78.6.381.10","doi-asserted-by":"publisher","DOI":"10.7326\/M14-0697"},{"key":"2025120619125878000_78.6.381.11","doi-asserted-by":"crossref","first-page":"1684","DOI":"10.3324\/haematol.2019.243287","article-title":"Whole-slide image analysis of the tumor microenvironment identifies low B-cell content as a predictor of adverse outcome in patients with advanced-stage classical Hodgkin lymphoma treated with BEACOPP","volume":"106","author":"Jachimowicz","year":"2021","journal-title":"Haematologica"},{"key":"2025120619125878000_78.6.381.12","doi-asserted-by":"publisher","DOI":"10.1111\/bjh.18762"},{"key":"2025120619125878000_78.6.381.13","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdy080"},{"key":"2025120619125878000_78.6.381.14","doi-asserted-by":"publisher","DOI":"10.1111\/bjh.18083"},{"key":"2025120619125878000_78.6.381.15","doi-asserted-by":"publisher","DOI":"10.6004\/jnccn.2022.0021"},{"key":"2025120619125878000_78.6.381.16","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.22799"},{"key":"2025120619125878000_78.6.381.17","doi-asserted-by":"publisher","DOI":"10.1039\/D2MO00195K"},{"key":"2025120619125878000_78.6.381.18","doi-asserted-by":"publisher","DOI":"10.1038\/s41375-022-01613-1"},{"key":"2025120619125878000_78.6.381.19","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199811193392104"},{"key":"2025120619125878000_78.6.381.20","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1000067"},{"key":"2025120619125878000_78.6.381.21","doi-asserted-by":"crossref","DOI":"10.3390\/diagnostics12040963","article-title":"The Need for Standardization in Next-Generation Sequencing Studies for Classic Hodgkin Lymphoma: A Systematic Review","volume":"12","author":"Santisteban-Espejo","year":"2022","journal-title":"Diagnostics (Basel)"},{"key":"2025120619125878000_78.6.381.22","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gkg509"},{"key":"2025120619125878000_78.6.381.23","doi-asserted-by":"crossref","unstructured":"Adzhubei I , Jordan DM , Sunyaev SR . Predicting Functional Effect of Human Missense Mutations Using PolyPhen\u20102. CP Human Genetics 2013;76. doi:10.1002\/0471142905.hg0720s76","DOI":"10.1002\/0471142905.hg0720s76"},{"key":"2025120619125878000_78.6.381.24","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/28.1.352"},{"key":"2025120619125878000_78.6.381.25","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2013.54.8800"},{"key":"2025120619125878000_78.6.381.26","doi-asserted-by":"publisher","DOI":"10.1111\/bjh.19255"},{"key":"2025120619125878000_78.6.381.27","doi-asserted-by":"crossref","first-page":"2076","DOI":"10.1200\/JCO.22.02473","article-title":"The Advanced-Stage Hodgkin Lymphoma International Prognostic Index: Development and Validation of a Clinical Prediction Model From the HoLISTIC Consortium","volume":"41","author":"Rodday","year":"2023","journal-title":"J Clin Oncol"},{"key":"2025120619125878000_78.6.381.28","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2011.39.9881"},{"key":"2025120619125878000_78.6.381.29","doi-asserted-by":"publisher","DOI":"10.1080\/10428194.2016.1239263"},{"key":"2025120619125878000_78.6.381.30","doi-asserted-by":"publisher","DOI":"10.1080\/10428190500220654"},{"key":"2025120619125878000_78.6.381.31","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2018.00267","article-title":"Acquired Natural Killer Cell Dysfunction in the Tumor Microenvironment of Classic Hodgkin Lymphoma","volume":"9","author":"Chiu","year":"2018","journal-title":"Front Immunol"},{"key":"2025120619125878000_78.6.381.32","doi-asserted-by":"crossref","DOI":"10.3390\/cancers14051360","article-title":"The Hodgkin Lymphoma Immune Microenvironment: Turning Bad News into Good","volume":"14","author":"Men\u00e9ndez","year":"2022","journal-title":"Cancers (Basel)"},{"key":"2025120619125878000_78.6.381.33","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-04-1869"},{"key":"2025120619125878000_78.6.381.34","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2017-03-770719"},{"key":"2025120619125878000_78.6.381.35","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2022.1000762","article-title":"Whole-slide image analysis identifies a high content of Hodgkin Reed-Sternberg cells and a low content of T lymphocytes in tumor microenvironment as predictors of adverse outcome in patients with classic Hodgkin lymphoma treated with ABVD","volume":"12","author":"Santisteban-Espejo","year":"2022","journal-title":"Front Oncol"},{"key":"2025120619125878000_78.6.381.36","doi-asserted-by":"publisher","DOI":"10.2174\/156652411795243423"},{"key":"2025120619125878000_78.6.381.37","doi-asserted-by":"publisher","DOI":"10.1038\/leu.2008.101"},{"key":"2025120619125878000_78.6.381.38","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2012-05-428896"},{"key":"2025120619125878000_78.6.381.39","doi-asserted-by":"publisher","DOI":"10.1038\/leu.2011.265"},{"key":"2025120619125878000_78.6.381.40","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2017-11-812073"},{"key":"2025120619125878000_78.6.381.41","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2005-09-3765"},{"key":"2025120619125878000_78.6.381.42","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2003-04-1197"},{"key":"2025120619125878000_78.6.381.43","doi-asserted-by":"publisher","DOI":"10.1111\/cas.12726"},{"key":"2025120619125878000_78.6.381.44","doi-asserted-by":"publisher","DOI":"10.1158\/2767-9764.CRC-23-0140"},{"key":"2025120619125878000_78.6.381.45","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2019.08.006"},{"key":"2025120619125878000_78.6.381.46","doi-asserted-by":"crossref","DOI":"10.1038\/s41392-020-00437-8","article-title":"CREBBP\/EP300 mutations promoted tumor progression in diffuse large B-cell lymphoma through altering tumor-associated macrophage polarization via FBXW7-NOTCH-CCL2\/CSF1 axis","volume":"6","author":"Huang","year":"2021","journal-title":"Signal Transduct Target Ther"},{"key":"2025120619125878000_78.6.381.47","doi-asserted-by":"crossref","first-page":"e98","DOI":"10.1111\/bjh.16738","article-title":"Clinical activity of ibrutinib in classical Hodgkin lymphoma relapsing after allogeneic stem cell transplantation is independent of tumor BTK expression","volume":"190","author":"Badar","year":"2020","journal-title":"Br J Haematol"},{"key":"2025120619125878000_78.6.381.48","doi-asserted-by":"crossref","DOI":"10.1002\/hon.3299","article-title":"Efficacy of escalating therapy with brentuximab vedotin-AVD in advanced stage Hodgkin lymphoma patients with positive interim positron emission tomography after ABVD","volume":"42","author":"Mart\u00ednez","year":"2024","journal-title":"Hematol Oncol"},{"key":"2025120619125878000_78.6.381.49","doi-asserted-by":"publisher","DOI":"10.1016\/S2352-3026(21)00102-2"},{"key":"2025120619125878000_78.6.381.50","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2206125"},{"key":"2025120619125878000_78.6.381.51","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2405888"},{"key":"2025120619125878000_78.6.381.52","doi-asserted-by":"publisher","DOI":"10.1016\/j.modpat.2024.100551"},{"key":"2025120619125878000_78.6.381.53","doi-asserted-by":"crossref","DOI":"10.1080\/2162402X.2024.2388304","article-title":"Multiplex spatial analysis reveals increased CD137 expression and m-MDSC neighboring tumor cells in refractory classical Hodgkin Lymphoma","volume":"13","author":"Sol\u00f3rzano","year":"2024","journal-title":"Oncoimmunology"},{"key":"2025120619125878000_78.6.381.54","first-page":"2343","article-title":"Spatial and molecular profiling of the mononuclear phagocyte network in classic Hodgkin lymphoma","volume":"141","author":"Stewart","year":"2023","journal-title":"Blood"},{"key":"2025120619125878000_78.6.381.55","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1200\/JCO.23.01115","article-title":"Spatially Resolved Tumor Microenvironment Predicts Treatment Outcomes in Relapsed\/Refractory Hodgkin Lymphoma","volume":"42","author":"Aoki","year":"2024","journal-title":"J Clin Oncol"},{"key":"2025120619125878000_78.6.381.56","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2023021003"}],"container-title":["Journal of Clinical Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/jcp-2024-209848","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,7]],"date-time":"2025-12-07T03:13:07Z","timestamp":1765077187000},"score":1,"resource":{"primary":{"URL":"https:\/\/jcp.bmj.com\/lookup\/doi\/10.1136\/jcp-2024-209848"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,20]]},"references-count":56,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2025,5,25]]},"published-print":{"date-parts":[[2025,6]]}},"alternative-id":["10.1136\/jcp-2024-209848"],"URL":"https:\/\/doi.org\/10.1136\/jcp-2024-209848","relation":{},"ISSN":["0021-9746","1472-4146"],"issn-type":[{"value":"0021-9746","type":"print"},{"value":"1472-4146","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1,20]]}}}